Drug Discovery

Our drug discovery group specializes in cancer and central nervous system drug research. Several major products including Taxol have been discovered at RTI, and we currently have several compounds in clinical trials.

We have expertise in pharmacology, synthetic chemistry, modeling, analytical, and identification techniques. Our extensive laboratory facilities give us the ability to conduct multiple projects in support of our clients' drug discovery programs.

Focus Areas

Our staff of principal investigators are highly skilled and experienced in the following areas of drug discovery:

Capabilities

  • Traditional, rational drug design methodologies
  • Combinatorial/array methodologies
  • Radiosynthesis
  • Nuclear magnetic resonance
  • Array synthesis

Principal Investigators

people-photo F. Ivy Carroll
Distinguished Fellow, Medicinal Chemistry
people-photo Jenny L. Wiley
Senior Fellow, Behavioral Pharmacology
people-photo Anthony Hickey
Distinguished Fellow, Aerosol and Nanomaterials Engineering